The efficacy of tamsulosin in facilitating expulsion of stones in the patients with distal urethral calculi.

Phase 2

Conditions: Distal ureteral calculi.
Calculus of ureter

Registration Number: IRCT201111168114N1

Lead Sponsor: Vice chancellor for research, Birjand University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 86

Inclusion Criteria

Exclusion criteria include: Multiple urethral stones; renal insufficiency; urinary tract infection; a solitary kidney; or pregnancy; history of urethral surgery; hypersensitivity to Tamsulosin; current alpha-blocker; calcium-antagonist medication; acute hydronephrosis; diabetic patients; hypertension; Obesity illnesses; use of another drugs at the same period (analgesic or anti-inflammatory ones), and complications of Tamsulosin (dizziness – tachycardia...).

Entrance criteria includes: all patients with stone size of 3-10mm.

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Of repelling stone. Timepoint: Once every three days, for 4 weeks. Method of measurement: The statements sick.

Secondary Outcome Measures

Name	Time	Method
The rate of consumption suppository diclofenac. Timepoint: once every three days, for 4 weeks. Method of measurement: The statements sick.;The days of repelling stone. Timepoint: once every three days, for 4 weeks. Method of measurement: According to answer the phone patients based on the removal of stone.